It is highlighted that successful clinical translation of CRISPR-based TB diagnostics is determined more by real-world adaptability than by analytical performance alone, and the variability in assay design, analytical and clinical performance, and translational readiness across currently available systems is evaluated.
A comprehensive evaluation of current applications demonstrates the efficacy of CRISPR-Cas12b-based diagnostics across diverse pathogens, including viruses, bacteria, and parasites, with a specific focus on its integration with isothermal amplification techniques.
Jiang-Ying Li, Xue-Yong Zhang· Current Issues in Molecular...· 0 citations
Evaluating the diagnostic performance of CRISPR-Cas12 systems integrated with isothermal amplification techniques for MTB detection demonstrates high diagnostic potential for TB detection, offering excellent sensitivity and specificity, rapid turnaround time, and suitability for point-of-care testing.
This review provides a structured overview of current LAMP-CRISPR platforms and highlights key technological considerations for translating rapid microbial pathogen detection from laboratory research to real-world applications.
Yi Xu, Xiao-Jiao He, Tian-Le Xu· Journal of Applied Microbiol...· 0 citations
Mycobacterium tuberculosis remains a major global public health threat, imposing significant socioeconomic burdens. Current molecular diagnostics rely heavily on nucleic acid extraction and specialized equipment, which limits their use in resource-limited settings. We developed a rapid, sensitive platform suitable for...
Jia-Yin Xing, Xiang-Xiang Zhao, Gao-Jie Wang et al.· Frontiers in Microbiology· 0 citations
An integrated framework that connects five coupled design layers with five levels of translational evidence shifts the evaluation of CRISPR diagnostics from isolated analytical performance toward evidence-based workflow co-design.
Heng-Yu Wang, Mei-You Chen, Qiu-Run He et al.· ACS Sensors· 0 citations